Indegene Limited (NSE:INDGN)

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Enterprise Medical Solutions	8.03B	6.01B	5.60B	4.32B	3.05B
Enterprise Medical Solutions Growth	33.57%	7.25%	29.81%	41.49%	28.26%
Enterprise Commercial Solutions	15.87B	15.29B	13.57B	10.16B	5.65B
Enterprise Commercial Solutions Growth	3.82%	12.66%	33.53%	79.99%	64.23%
Others	1.02B	1.41B	1.06B	754.78M	305.27M
Others Growth	-27.66%	32.64%	40.84%	147.25%	-
Brand Activation	3.48B	3.19B	2.83B	1.41B	787.38M
Brand Activation Growth	8.96%	12.88%	99.91%	79.60%	28.33%
Total	28.39B	25.90B	23.06B	16.65B	9.79B
Total Growth	9.64%	12.29%	38.54%	70.06%	52.25%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Europe	7.61B	7.95B	6.31B	4.64B	6.31B
Europe Growth	-4.24%	25.96%	36.11%	-26.53%	625.83%
India	194.00M	223.00M	356.00M	274.15M	355.60M
India Growth	-13.00%	-37.36%	29.86%	-22.90%	20.70%
North America (Excluding United States of America)	178.00M	8.00M	62.00M	6.32M	62.21M
North America (Excluding United States of America) Growth	2125.00%	-87.10%	881.01%	-89.84%	15.80%
Rest of The World	675.00M	626.00M	650.00M	471.61M	651.13M
Rest of The World Growth	7.83%	-3.69%	37.83%	-27.57%	53.58%
United States of America	19.74B	17.09B	15.68B	11.35B	15.68B
United States of America Growth	15.47%	8.98%	38.17%	-27.62%	227.57%
Total	28.39B	25.90B	23.06B	16.74B	23.06B
Total Growth	9.64%	12.29%	37.77%	-27.42%	258.69%

Source: S&P Global Market Intelligence.